Plasmodium Falciparum: Inhibition of in Vitro Growth by Desferrioxamine

Carmen Raventos-SuarezDivision of Experimental Hematology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461

Search for other papers by Carmen Raventos-Suarez in
Current site
Google Scholar
PubMed
Close
,
Simeon PollackDivision of Experimental Hematology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461

Search for other papers by Simeon Pollack in
Current site
Google Scholar
PubMed
Close
, and
Ronald L. NagelDivision of Experimental Hematology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461

Search for other papers by Ronald L. Nagel in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

Infectious agents must acquire iron from their host to survive, and iron deficiency has been reported to protect against malaria in humans. We have tested the the susceptibility of Plasmodium falciparum to iron deprivation by studying the effect of desferrioxamine (DF), a specific iron chelating agent, on parasite growth in an in vitro culture system. We have found that DF inhibits the growth of P. falciparum at concentrations readily achievable in vivo, by a mechanism that may involve interference with the completion of schizogony.

Save